ABOUT GlobeImmune NEWSROOM CAREERS CONTACT US INVESTORS PLATFORM CANCER INFECTIOUS DISEASE GlobeImmune is developing Tarmogen product candidates to treat cancer and infectious diseases. Tarmogens® – TARGETED MOLECULAR IMMUNOTHERAPY® Tarmogens activate the immune system by stimulating a subset of white blood cells called T cells that destroy infected or malignant cells, in contrast to traditional vaccines, which predominately stimulate antibody production. Tarmogens target the molecular profile that distinguishes a diseased cell from a normal cell, and are designed to target specific antigens that play a role in oncology indications and infectious diseases. READ MORE » ALL NEWS » RECENT NEWS 08/28/2017 Globeimmune Provides Update on Recent Clinical Trial Developments 03/23/2017 GlobeImmune Announces Majority Stock Sale 11/17/2016 GlobeImmune Announces Updates SITE MAP » CONTACT US » CURRENT EMPLOYEES / INTRANET » Copyright © GlobeImmune Inc. All Rights Reserved. Corporate Headquarters 1450 Infinite Drive Louisville, Colorado 80027 Phone: 720.667.2300